T/HENANPA 011-2023 Evaluating index system for calcium channel blocker drugs in medical institutions

Scope

Main technical content: The "Evaluation Index System for Calcium Channel Blockers in Medical Institutions" follows the principles of openness, transparency, and fairness, takes relevant guidelines as the theoretical basis, combines the characteristics of clinical drug use, and widely adopts the opinions of medical institutions' drug users, monitors, and managers. The evaluation standards are highly scientific, specific, and timely, and can be used for reference by medical institutions at all levels. It is conducive to promoting the selection of drug lists in medical and health institutions and the connection between drug lists of superior and subordinate medical and health institutions, improving the level of pharmaceutical services and rational use of calcium channel blockers, controlling unreasonable drug expenditure, and enhancing the efficiency of health resource allocation. It has great application value.

Development Information

Related Standards